Therapeutic use of blood products for the treatment of autoimmune hemolytic anemia: A network meta-analysis protocol
View ORCID ProfileJiawen Deng
doi: https://doi.org/10.1101/2020.01.15.20017657
Jiawen Deng
1Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
Data Availability
All available data are disclosed in the manuscript.
Posted January 21, 2020.
Therapeutic use of blood products for the treatment of autoimmune hemolytic anemia: A network meta-analysis protocol
Jiawen Deng
medRxiv 2020.01.15.20017657; doi: https://doi.org/10.1101/2020.01.15.20017657
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)